Recital 8, Regulation (EU) 2025/1150

In forcesince 11 Jun 2025

The requested use of sodium ascorbate (E 301) in microencapsulated vitamin A preparations results in the same maximum carry-over level to infant formula and follow-on formula as the level assessed by the Authority in 2010. Moreover, the maximum amounts for vitamin C and sodium authorised in infant formula and follow-on formula cover their presence from all sources, including carry-over of food additives. Therefore, the proposed extension of use of sodium ascorbate (E 301) is not liable to have an effect on human health.